| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1a3639ea3024d1e99afdb8fb1874912e |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00 |
| filingDate |
2012-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dafabab0b0e2f1022bc785da83527242
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a30edda038da2e6116236eee62ce2e70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9d2d9b4ffbe6215231a17cbd9a589462 |
| publicationDate |
2014-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-2014036733-A |
| titleOfInvention |
Biomaterial composed of β-type tricalcium phosphate |
| abstract |
A biomaterial ceramic in which silicic acid is substituted and dissolved in a phosphoric acid position in a β-type tricalcium phosphate structure, or a biomaterial in which silicon is substituted and dissolved in a phosphorous position in a β-type tricalcium phosphate structure. Provide ceramics. SOLUTION: Magnesium (Mg 2+ ion) in Ca (4) site and Ca (5) site, sodium (Na + ion) in pore of Ca (4) site, phosphorus in P (1) site (P 5 + ions) to produce a beta-TCP which has clearly substituted solid solution of silicon (Si 4+ ions). [Selection] Figure 6 |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015173788-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11013824-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018167016-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-7097544-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017038647-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018181245-A1 |
| priorityDate |
2012-08-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |